RAPT vs SOFI · $132.1M cap vs P/E 39, rev $283.1M
RAPT Therapeutics Inc (RAPT) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
RAPT currently screens at market cap $132.1M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the RAPT and SOFI stock pages for the full models.
Not investment advice.